tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
Global Blood Therapeutics's activity chart (see below) currently has 207 price targets and 167 ratings on display.
Analysts average stock forecasts to be materialized ratio is 53.58% with an average time for these price targets to be met of 330.07 days.
Most recent stock forecast was given by from TD COWEN on 09-Aug-2022. First documented stock forecast 08-Sep-2015.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 08-Sep-2015
$68.5
$0.01 (0.01%)
$67
4 years 2 months 12 days ago
(09-Aug-2022)
7/9 (77.78%)
$1.91 (2.87%)
825
Buy Since 14-Apr-2021
$68.5
$0.01 (0.01%)
$53
4 years 2 months 12 days ago
(09-Aug-2022)
4/5 (80%)
$1.91 (2.87%)
290
Buy Since 01-Apr-2019
$68.5
$0.01 (0.01%)
$133
4 years 2 months 12 days ago
(09-Aug-2022)
1/6 (16.67%)
$1.91 (2.87%)
567
Buy Since 03-Dec-2020
$68.5
$0.01 (0.01%)
$60
4 years 2 months 12 days ago
(09-Aug-2022)
2/5 (40%)
$1.91 (2.87%)
274
Buy Since 11-Mar-2021
$68.5
$0.01 (0.01%)
4 years 2 months 13 days ago
(08-Aug-2022)
2/3 (66.67%)
$1.9 (2.85%)
426
What is GBT (Global Blood Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on GBT (Global Blood Therapeutics)?
Which analyst has the most public recommendations on GBT (Global Blood Therapeutics)?
Which analyst is the currently most bullish on GBT (Global Blood Therapeutics)?
Which analyst is the currently most reserved on GBT (Global Blood Therapeutics)?
